SK Bioscience Co. Ltd. and Vaxxas Pty. Ltd. have entered into a joint development agreement that could revolutionize vaccines by developing a vaccine-delivery device combination product using Vaxxas’ high-density microarray patch (HD-MAP) coupled with SK Bioscience’s typhoid vaccine, Skytyphoid.
three times now. i know and we ve had nothing, thank goodness. why is it so mild? don t know the yet. that will be somebody s ph.d. map paper. are we close to the end of hurricane season? it s code outside. when it s cold, the hurricane season goes away. we re close to the end. still a chance for a gulf storm though. we might be in the clear. we re talking three weeks or so? four. keep your first, crossed. thank you, chad. appreciate it. he has been a prisoner north korea for the past 11 months. still to come, american kenneth baes mother finally gets a chance to see him. she s talking exclusively to cnn about her recent visit. also her worst fears. (vo) you are a business pro.